Amorepacific Corporation

Han Byul Kim

Jin Young Lee

Youn Joon Kim

Byung Young Kang

Jin Sup Shim

Ji Seong Kim

Dong Won Choi

Hyang Tae Choi

Ji Hyun Bae

Hong Guen Park

In Hye Ha

Young Ho Park

Do Hoon Kim

Jun Seong Park

Song Seok Shin

Hyung Jun Lim

Ji Hyun Lee

Jae Won Yoo

Jung A Kim

Sung Hoon Lee

Disclosed herein is a skin external composition containing a red yeast rice extract. More particularly, disclosed is a skin external composition containing a red yeast rice extract which can increase the production of loricrin in keratinocytes and to strengthen the skin barrier function, thereby exhibiting an excellent effect of improving skin moisturization.

Skin external composition for skin moisturization containing red yeast rice extract

The present invention relates to a microcapsule containing a glycoprotein derived from plants. Also, the present invention provides a microcapsule having oxidation ability and which is easy to prepare. Through said antioxidant capacity, oxidation and decomposition of an internally contained material can be prevented. According to the microcapsule of the present invention, the active components, in a form which was previously stabilized by a synthetic polymer derived from crude oil or by a surfactant, can be stabilized by naturally derived components. Also, since an organic solvent is not additionally used during the capsule preparation process, the preparation is simple and eco-friendly.

Microcapsule comprising glycoprotein derived from plants

The present invention relates to a topical composition for use on skin containing theanine derivatives as active components and, more particularly, to a topical composition for use on skin having anti-aging, skin wrinkle repair, skin barrier enhancement, skin immunity enhancement, skin moisturizing, and atopy alleviation effects by containing theanine derivatives as active components.

Topical composition containing theanine derivatives for use on skin

Disclosed is a method for screening a substance inhibiting inflammatory skin aging, comprising: treating an immune cell with an inflammatory stimulant; treating a skin cell with a candidate substance; treating the skin cell treated with the candidate substance, with the immune cell treated with the inflammatory stimulant; and measuring the concentration of matrix metalloproteinase-1 (MMP-1) in the skin cell treated with the immune cell.

Method for screening inhibitory substances to inflammatory skin-aging

Growing community of inventors

Yongin-si, South Korea

Han Byul Kim